Lipid A fraction of LPS induces a discrete MAPK activation in acute lung injury

Wen-Feng Fang1, Jae Hwa Cho, Qianbin He

  • 1Divisio of Pulmonary Sciences and Critical Care Medicine, University of Colorado at Denver, Health Sciences Center, Denver, CO 80204, USA.

Insights

Lipopolysaccharide's lipid A fraction amplifies lung inflammation and ERK activation in mice, distinct from whole LPS. This suggests lipid A drives specific inflammatory responses in acute lung injury.

Area of Science:

  • Immunology
  • Pulmonology
  • Molecular Biology

Background:

  • Lipopolysaccharide (LPS) triggers acute lung injury (ALI) through Toll-like receptor 4 (TLR4) and MAPK pathways.
  • The lipid A component of LPS is recognized as the primary active moiety.
  • The precise role of lipid A in ALI-associated MAPK activation in vivo remains incompletely understood.

Purpose of the Study:

  • To investigate the specific contribution of the lipid A fraction of LPS to MAPK activation and acute lung injury in a murine model.
  • To compare the inflammatory and MAPK activation patterns induced by purified lipid A versus whole LPS.

Main Methods:

  • Mice received intratracheal instillations of purified lipid A, LPS, or vehicle.
  • Acute lung injury was assessed via histology.
  • Myeloperoxidase (MPO) activity and MAPK (specifically ERK) expression were quantified in lung tissue.
  • In vitro studies utilized macrophages to examine ERK activation and cytokine expression.

Main Results:

  • Lipid A induced significantly higher MPO activity compared to LPS at 6 hours post-instillation.
  • Despite increased MPO, ALI scores were comparable between lipid A and LPS treatments at 6 and 24 hours.
  • Phospho-ERK activation was more pronounced following lipid A administration than LPS.
  • In vitro, lipid A and LPS stimulated ERK activation and cytokine expression in macrophages.

Conclusions:

  • The lipid A fraction of LPS induces amplified MPO activity and ERK activation in the lung compared to whole LPS.
  • While lipid A drives specific inflammatory markers and MAPK activation, it results in ALI scores comparable to whole LPS.
  • These findings highlight a distinct inflammatory profile associated with LPS lipid A in acute lung injury.

Related Concept Videos

Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
Acute Inflammation II: Cellular Phase01:26

Acute Inflammation II: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...